XML 88 R69.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value Measurements - Assets and Liabilities at Fair Value (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Mar. 31, 2022
Other current liabilities:      
Contingent consideration obligations $ 294.3 $ 291.2  
Other non-current liabilities:      
Contingent consideration obligations 228.1    
Samsung Bioepis      
Other non-current liabilities:      
Equity, ownership interest     49.90%
Fair Value, Measurements Recurring      
Assets:      
Cash equivalents 2,109.0 1,664.9  
Marketable equity securities 146.9 179.7  
Derivative contracts 40.2 62.5  
Plan assets for deferred compensation 47.8 42.8  
Total 2,343.9 1,949.9  
Other current liabilities:      
Derivative contracts 32.5    
Contingent consideration obligations 294.3 291.2  
Other non-current liabilities:      
Derivative contracts 0.8    
Contingent consideration obligations 228.1 221.6  
Total 555.7 524.5  
Derivative contracts   11.7  
Total 555.7 524.5  
Quoted Prices in Active Markets (Level 1) | Fair Value, Measurements Recurring      
Assets:      
Cash equivalents 0.0 0.0  
Marketable equity securities 146.9 179.7  
Derivative contracts 0.0 0.0  
Plan assets for deferred compensation 0.0 0.0  
Total 146.9 179.7  
Other current liabilities:      
Derivative contracts 0.0    
Contingent consideration obligations 0.0 0.0  
Other non-current liabilities:      
Derivative contracts 0.0    
Contingent consideration obligations 0.0 0.0  
Total 0.0 0.0  
Derivative contracts   0.0  
Total 0.0 0.0  
Significant Other Observable Inputs (Level 2) | Fair Value, Measurements Recurring      
Assets:      
Cash equivalents 2,109.0 1,664.9  
Marketable equity securities 0.0 0.0  
Derivative contracts 40.2 62.5  
Plan assets for deferred compensation 47.8 42.8  
Total 2,197.0 1,770.2  
Other current liabilities:      
Derivative contracts 32.5    
Contingent consideration obligations 0.0 0.0  
Other non-current liabilities:      
Derivative contracts 0.8    
Contingent consideration obligations 0.0 0.0  
Total 33.3 11.7  
Derivative contracts   11.7  
Total 33.3 11.7  
Significant Unobservable Inputs (Level 3) | Fair Value, Measurements Recurring      
Assets:      
Cash equivalents 0.0 0.0  
Marketable equity securities 0.0 0.0  
Derivative contracts 0.0 0.0  
Plan assets for deferred compensation 0.0 0.0  
Total 0.0 0.0  
Other current liabilities:      
Derivative contracts 0.0    
Contingent consideration obligations 294.3 291.2  
Other non-current liabilities:      
Derivative contracts 0.0    
Contingent consideration obligations 228.1 221.6  
Total 522.4 512.8  
Derivative contracts   0.0  
Total $ 522.4 $ 512.8